
Everything you need to know about macular degeneration
Hear this story
Many of us are painfully aware of our body's increasing number of shortcomings as we get older. Sagging skin, hearing loss, receding hairlines and tending to use the bathroom more frequently than we used to.
But one of the most dreaded adverse outcomes is that of diminishing eyesight. Reduced vision, also known as vision impairment, is so common that research shows that nearly 30% of U.S. adults 71 and older have it. While many factors can contribute to it occurring, the leading cause of vision loss in older adults is age-related macular degeneration, according to the U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion.
Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.
What is macular degeneration? What is AMD, wet AMD?
Macular degeneration, also known as age-related macular degeneration or AMD, is an incurable eye disease that damages the middle part of the retina that's known as the macula, "which is responsible for our central, detailed vision," explains Laura Di Meglio, OD, an assistant professor of ophthalmology at the Wilmer Eye Institute at Johns Hopkins University School of Medicine.
Need a break? Play the USA TODAY Daily Crossword Puzzle.
When this area of the eye is damaged, it leads to a gradual loss of sharp central vision, seeing dark spots, distorted or wavy vision and difficulty seeing colors. In these ways, "AMD can severely impact quality of life by making it harder to see fine details even though it doesn't cause total blindness," says Inna Lazar, a Connecticut-based optometrist and founder of Greenwich Eye Care.
Some such adverse impacts include difficulty driving or with close-up activities like reading, writing, cooking, sewing or fixing things around the house. People with AMD can even have problems recognizing faces, Lazar says.
Symptoms vary though as there are two types of AMD: dry AMD and wet AMD. "Dry AMD is very common with about 80% of people with AMD having this form," says Dr. Purnima Patel, an ophthalmologist at ORA Vision in Georgia and spokesperson for the American Academy of Ophthalmology. It is characterized by the macular gradually getting thinner with age. "Wet AMD is less common, but affects sight much quicker," says Patel. It occurs when abnormal blood vessels grow in the back of the eye and damage the macula.
In case you missed:Here's why it's so important to catch and treat glaucoma early
What causes macular degeneration?
More than 20 million Americans have AMD, per the American Macular Degeneration Foundation, but your risk of developing it significantly increases with age. Aging is the single biggest contributor of AMD, in part, because cell regeneration slows down as we get older, which is one of the highest risk factors associated with diminished eyesight.
Several other factors are also thought to contribute to the development of AMD. These include a family history of the condition, your race (Caucasians have been shown to be at higher risk, Patel says), and environmental factors such as "smoking, excessive UV exposure, poor diet, high blood pressure and obesity, all of which can damage the delicate blood vessels that nourish the macula," says Lazar.
Elsewhere in eye issues:Kids' eyesight is getting worse. Special contact lenses may be the answer.
How is macular degeneration prevented and treated?
No matter which associated risk factors you may be facing, there are ways of preventing or at least diminishing the worst outcomes of the condition. These include "making healthy lifestyle and dietary choices like eating leafy greens and omega-3s, quitting smoking, staying active and keeping your blood pressure in check," says Lazar.
Once AMD has been diagnosed, a handful of treatment options are available depending on which type of AMD you're dealing with. "To treat wet AMD, ophthalmologists usually use medications called anti-VEGF drugs," says Patel. She explains that anti-VEGF drugs are delivered through a very thin needle and can help stop the leaking of the vessels. "This can slow or stop worsening of the vision and can often even improve vision," she explains.
It's best to consult with your eye care professionals about the best courses of action, especially if you notice symptoms worsening. "It is important for patients with macular degeneration to routinely check their vision in each eye," adds Di Meglio, "and to notify their eye care provider if they notice any changes as quick treatment can help prevent further irreversible damage."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Researchers issue urgent warning over spread of dangerous disease carried by snails: 'Leading to outbreaks in new locations'
Harmful parasites carried by snails may be spreading, in part due to human-caused climate change, according to reporting from The Telegraph in May. Marginalized populations, including women and girls, may suffer disproportionately from increased prevalence. Schistosomiasis is a parasitic infection caused by snail-carried worms. Infection typically starts with making contact with the worms in freshwater, such as in a canal, river, or pond. Person-to-person transmission can continue when urine or feces containing the parasite's eggs contaminates a water source. Symptoms — including fever, chills, coughing, and aches — can manifest within a couple of months, per the Centers for Disease Control and Prevention. Chronic infections can lead to anemia, bloody stools, urinary problems, organ damage, and more. Historically, 90% of the schistosomiasis cases requiring treatment have been located in Africa, but infections have also been documented in Asia, the Americas, and the Middle East. While the London-based outlet has reported more recent spreading in parts of Europe may be largely tourism- and migration-driven, researcher Bonnie Webster also told the publication that transmissions may emerge in further locations due to shifting weather patterns. Rising global temperatures are driving more frequent and more intense flooding events, causing snails to appear in new wet settings and increasing water contamination. "Climate change will likely cause dramatic changes in transmission which need to be understood," Webster, who studies the disease at London's Natural History Museum, told The Telegraph. "Some areas will become drier and other areas will become flooded, creating new water bodies. This will lead to snails changing where they can be found and cause the prevalence of schistosomiasis to increase and spread, leading to outbreaks in new locations." Communities in low- and middle-income countries lacking sufficient sanitation infrastructure are already disproportionately impacted by this serious issue, and women and girls are additionally vulnerable to its effects. All people can become infected by these parasites, but one manifestation of the disease — female genital schistosomiasis, or FGS — can cause sexual, reproductive, and other health concerns for women and girls. Gendered labor dynamics can make this group additionally susceptible to infection through activities like washing laundry in contaminated water. Unlimit Health says that around 56 million women and girls in sub-Saharan Africa are infected with FGS, which can go undiagnosed and, especially when misdiagnosed as a sexually transmitted infection or otherwise left untreated, can lead to bleeding, pelvic pain, ulcers, miscarriage, and infertility. It may also contribute to increased risks of HIV and cervical cancer. Overall, schistosomiasis impacts hundreds of millions of people each year, resulting in up to 20,000 deaths annually, according to The Telegraph. Unfortunately, as Webster said, "Once one snail is infected, they can infect a whole population of humans." Do you worry about getting diseases from bug bites? Absolutely Only when I'm camping or hiking Not really Never Click your choice to see results and speak your mind. While treatments exist, potential drug resistance and current medical shortages could hamper attempts to curtail infections. Experts relayed to The Telegraph that recent substantial cuts to the United States Agency for International Development may also stymie research and response efforts for neglected tropical diseases like schistosomiasis. NTDs disproportionately impact marginalized populations. The World Health Organization says they affect over 1 billion people globally and that NTDs are "often related to environmental conditions." Of course, because of travel and climate change, many such infections may spread to more communities and farther regions. The CDC notes that prevention includes clean-up of contaminated areas, implementation of sanitation systems, and avoiding swimming, wading, and washing in unsafe water. A number of these measures require funding. Staying updated about how human-caused climate change can impact health and well-being everywhere can be key to organizing effective responses to rising global temperatures. Especially together in groups, friends and neighbors can make a difference by exploring these issues, raising awareness, supporting pro-environment policies, and taking on climate-conscious shifts at home to help address the extreme weather that imperils billions worldwide. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
an hour ago
- Yahoo
Rockefeller Foundation Releases New Polling Data: Majority of Americans Want Food is Medicine Programs
Nearly 80% of Americans think food and nutrition should be covered by insurance to address chronic disease NEW YORK, June 12, 2025 /PRNewswire/ -- New polling data from The Rockefeller Foundation shows that more than four in five adults in the United States – across demographics, income levels, party affiliations, and geographies – support integrating Food is Medicine (FIM) programs into U.S. healthcare. The survey, conducted by Hattaway Communications, highlights high interest but low public awareness of FIM programs, which aim to treat and manage chronic disease by increasing access to nutritious foods. The research underscores the perceived benefits of Food is Medicine programs, with 79% of respondents reporting that FIM programs would personally help them eat better after they received a definition of the intervention. "Americans want nutrition and food solutions to help them eat better, improve their health, and save money," said Dr. Rajiv J. Shah, President of The Rockefeller Foundation. "We know that these programs are effective in helping patients manage diet-related chronic disease and are cost-effective too. Now, it's even clearer that there is a huge opportunity to improve Americans' health outcomes by investing in low-cost, individualized Food is Medicine solutions that are both proven and popular." Chronic diseases, such as diabetes, obesity, and heart disease, impact an estimated 133 million Americans—more than 38% (or one-third) of the total U.S. population—and cost the United States $1.1 trillion per year (equivalent to what the U.S. spends on food itself). The vast majority of chronic conditions are diet-related: In the United States alone, poor diets contribute to 500,000 deaths annually. Modeling on medically tailored meals shows that investing in FIM programs could save an estimated $32.1 billion a year, significantly reducing Americans' healthcare costs. Even still, only 13% of Americans polled said they knew about FIM programs, which include interventions such as medically tailored meals and prescriptions for accessing fruits and vegetables, coupled with nutrition support. When presented with the definition of what they entail, survey respondents (84%) resoundingly supported the efforts. Some of the key findings include: More than 4 in 5 Americans believe U.S. healthcare should offer more food and nutrition programs to treat and manage illnesses. Nearly 9 in 10 patients would prefer to rely more on healthy eating than on medications to manage their conditions. Nearly 4 in 5 Americans think that Food is Medicine programs should be covered by both public and private insurance, including 85% of self-identified Democrats and 78% of Republicans. 84% of respondents believed FIM could help improve the overall quality of health in the United States. 79% of respondents said FIM programs could help them personally. 49% of the American public and 67% of healthcare workers view high costs of nutritious food as the single largest barrier to eating well. "We are seeing a growing awareness of diet-related diseases and their consequences in the U.S.," said Devon Klatell, Vice President for the Food Initiative at The Rockefeller Foundation. "This polling data shows that Americans want more support to eat well and live well. Food is Medicine programs are one tool that health care practitioners and providers must be considering as they work to address chronic disease in America." The Rockefeller Foundation commissioned Hattaway Communications to conduct the survey, which polled respondents across all 50 states between February 28 and March 11, 2025. The survey sampled 2,271 respondents, including 1,135 patients and 399 healthcare workers. The sample was weighted by gender and education to align with the actual proportions within the population and is representative of racial demographics across the U.S. Since 2019, The Rockefeller Foundation has supported Food is Medicine programs and invested in research to improve their effectiveness and understand the benefits and costs. As part of this effort, The Foundation announced its $100 million investment to expand access to Food is Medicine, including supporting vital research like the American Heart Association's Health Care by Food Initiative. The Foundation also initiated partnerships with the U.S. Department of Veterans Affairs and the U.S. Department of Health and Human Services to speed the integration of Food Is Medicine into health systems. In February 2025, The Rockefeller Foundation announced $3.5 million in grant funding to support small and mid-scale U.S. farmers, improve health outcomes for people with chronic disease, mitigate rising health care costs in California, Hawaii, Maryland, Massachusetts, Mississippi, North Carolina, Oregon, Rhode Island, Virginia, and Washington, D.C., and advance state-based efforts to include FIM interventions as a medically covered benefit under Medicaid programs. About The Rockefeller FoundationThe Rockefeller Foundation is a pioneering philanthropy built on collaborative partnerships at the frontiers of science, technology, and innovation that enable individuals, families, and communities to flourish. We make big bets to promote the wellbeing of humanity. Today, we are focused on advancing human opportunity and reversing the climate crisis by transforming systems in food, health, energy, and finance. For more information, sign up for our newsletter at and follow us on X @RockefellerFdn and LinkedIn @the-rockefeller-foundation. Media Contact:Ashley Chang, The Rockefeller Foundation: media@ View original content: SOURCE The Rockefeller Foundation Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
RFK Jr.'s newest CDC vaccine panel includes critics of COVID shots, lockdowns
The Brief U.S. Health Secretary Robert F. Kennedy Jr. has replaced the government's vaccine advisory panel with eight new appointees. The new members include vocal critics of COVID-19 vaccines and pandemic lockdowns, such as Dr. Robert Malone and Dr. Martin Kulldorff. Public health groups have raised concerns that Kennedy's changes could undermine long-standing vaccination policies. NEW YORK - U.S. Health Secretary Robert F. Kennedy Jr. has named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. His selections include a scientist who researched mRNA vaccine technology and transformed into a conservative darling for his criticisms of COVID-19 vaccines, and a leading critic of pandemic-era lockdowns. RELATED: RFK Jr. ousts entire CDC vaccine panel Kennedy made the announcement in a social media post on Wednesday. The backstory Kennedy's decision to "retire" the previous 17-member panel was widely decried by doctors' groups and public health organizations, who feared the advisers would be replaced by a group aligned with Kennedy's desire to reassess — and possibly end — longstanding vaccination recommendations. Dig deeper The new appointees to the Advisory Committee on Immunization Practices include Dr. Robert Malone, the former mRNA researcher who emerged as a close adviser to Kennedy during the measles outbreak. Malone, who runs a wellness institute and a popular blog, rose to popularity during the COVID-19 pandemic as he relayed conspiracy theories around the outbreak and the vaccines that followed. He has appeared on podcasts and other conservative news outlets where he's promoted unproven and alternative treatments for measles and COVID-19. He has claimed that millions of Americans were hypnotized into taking the COVID-19 shots. He's even suggested that those vaccines cause a form of AIDS. He's downplayed deaths related to one of the largest measles outbreaks in the U.S. in years. Other appointees include Dr. Martin Kulldorff, a biostatistician and epidemiologist who was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm. Dr. Cody Meissner, a former ACIP member, also was named. Big picture view The committee, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention. CDC directors almost always approve those recommendations on how Food and Drug Administration-cleared vaccines should be used. The CDC's final recommendations are widely heeded by doctors and determine the scope of vaccination programs. The Source The Associated Press contributed to this report. The information in this story comes from a social media announcement made by U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday, in which he introduced eight new members to the federal vaccine advisory panel. This story was reported from Los Angeles.